Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Gunnebo in connection with the divestment of its Cash Management business
Mandate

Vinge advises Gunnebo in connection with the divestment of its Cash Management business

February 01, 2022 General Corporate IT, Telecommunications and Outsourcing M&A Intellectual Property Carve-Outs

Vinge advises Gunnebo Aktiebolag (“Gunnebo”) in connection with the divestment of its Cash Management business to Sesami Cash Management Technologies Corporation, a cash ecosystem solution company controlled by GardaWorld Security Corporation.

The Cash Management business includes automated cash handling solutions, software and services for closed cash handling, cash recycling and cash deposit, for the purpose of creating a safer and more efficient cash cycle and reducing the cost of handling notes and coins.

The divestment is part of Gunnebo’s transformation journey started in 2020, leaving the integrated security and the cash management segments, to be able to focus on the global leading market positions within the business units Entrance Control and Safe Storage.

The transaction is expected to be closed by 1 March 2022.

Vinge’s team consisted of Christina Kokko, Matthias Pannier, Maria Dahlin Kolvik, Viktor Lennartsson and Nina Fathjalali (M&A), Mathilda Persson and Martin Boström (Commercial Agreements/IT), Stojan Arnerstål and Michael Montner (IP), and Cathrin Larsson, Sara Dahlros Sköld and Christoffer Widström (VDR).

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026